Related references
Note: Only part of the references are listed.Type 3 inositol 1,4,5-trisphosphate receptor: A calcium channel for all seasons
Anjali Mangla et al.
CELL CALCIUM (2020)
Lipid metabolism as a mechanism of immunomodulation in macrophages: the role of liver X receptors
Sophia Leussink et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
Gaia Giannone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance
Lung-Yi Mak et al.
JOURNAL OF HEPATOLOGY (2020)
The clinical importance of CD4+CD7- in human diseases
Saeed Mohammadian Haftcheshmeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Immune checkpoint inhibitors
Enfu Hui
JOURNAL OF CELL BIOLOGY (2019)
A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers
Wai Hoong Chang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
A novel 4-gene prognostic signature for hypermutated colorectal cancer
Weiting Ge et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients
Gui-Qi Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life
Daneng Li et al.
CANCERS (2019)
Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
Dan Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Liver-associated immune abnormalities
Eyal Grunebaum et al.
AUTOIMMUNITY REVIEWS (2019)
Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Michael J. Flynn et al.
HEPATOLOGY (2019)
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia
Diogo Gomes-Silva et al.
MOLECULAR THERAPY (2019)
Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment
Jennifer Wang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
Immune Responses in the Liver
Paul Kubes et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction
Zhenglu Wang et al.
LIFE SCIENCES (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
Chuan Xing Wu et al.
THERANOSTICS (2018)
Downregulation of Activin A Receptor Type 2A Is Associated with Metastatic Potential and Poor Prognosis of Colon Cancer
Changhua Zhuo et al.
JOURNAL OF CANCER (2018)
Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma A meta-analysis
Wei Ding et al.
MEDICINE (2018)
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
Serena De Matteis et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
Yujia Zheng et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma
Li-Jie Ma et al.
THERANOSTICS (2018)
IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients
Heba Mosaad Elsayed et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
Naoshi Nishida et al.
ONCOLOGY (2017)
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Galina Khemlina et al.
MOLECULAR CANCER (2017)
Alternative Polyadenylation of PRELID1 Regulates Mitochondrial ROS Signaling and Cancer Outcomes
Austin E. Gillen et al.
MOLECULAR CANCER RESEARCH (2017)
Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer
Cristina Perez-Ramirez et al.
SURGICAL ONCOLOGY-OXFORD (2017)
The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis
Wei Yao et al.
SCIENTIFIC REPORTS (2017)
Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Hae Il Jung et al.
CANCER RESEARCH AND TREATMENT (2017)
Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
Binghua Li et al.
SCIENTIFIC REPORTS (2017)
Characterization of the Immune Microenvironment in Hepatocellular Carcinoma
Mark Yarchoan et al.
CLINICAL CANCER RESEARCH (2017)
Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology
Raghuveera Kumar Goel et al.
CANCER AND METASTASIS REVIEWS (2016)
Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
Philip D. Dunne et al.
ONCOTARGET (2016)
Tobacco smoke induces production of chemokine CCL20 to promote lung cancer
Gui-Zhen Wang et al.
CANCER LETTERS (2015)
Fyn is an important molecule in cancer pathogenesis and drug resistance
Daniel Elias et al.
PHARMACOLOGICAL RESEARCH (2015)
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question
Letitia Adela Maria Streba et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The Association Between Metabolic Syndrome and Hepatocellular Carcinoma Systemic Review and Meta-analysis
Raxitkumar Jinjuvadia et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma
Qiu-Zhong Pan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology
Luigi Racioppi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
Valerie Chew et al.
JOURNAL OF HEPATOLOGY (2010)
CCL20/CCR6 expression profile in pancreatic cancer
Claudia Rubie et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Interactions of IL-12A and IL-12B Polymorphisms on the Risk of Cervical Cancer in Chinese Women
Xiaojun Chen et al.
CLINICAL CANCER RESEARCH (2009)
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals
F Navaglia et al.
JOURNAL OF MEDICAL GENETICS (2005)
PRELI, the human homologue of the avian px19, is expressed by germinal center B lymphocytes
L Guzman-Rojas et al.
INTERNATIONAL IMMUNOLOGY (2000)
Share Paper
